CBD in pharmacies

In 2025, CBD in pharmacies is no longer just a simple wellness supplement: it's becoming a true health player. Between strengthened legislation, new authorized molecules, and pharmaceutical oversight, cannabidiol is establishing itself on pharmacy shelves with more seriousness than ever before. But what can you really find in pharmacies? Is it safe? And most importantly, is it effective? Here's a comprehensive overview, based on the latest publications from December 2025.

Key publications of 2025 on CBD in pharmacies

A comprehensive guide to legal CBD products in 2025

French legislation in 2025 remains strict: to be sold legally, a CBD product must contain less than 0.3% THC and come from hemp varieties authorized by the European Union. But this year, new molecules such as CPR, THC-X, and muscimol have been validated for controlled use in pharmacies. These innovations have allowed the French CBD market to reach 900 million euros by the end of 2025, particularly thanks to a diversification of products: sublingual oils, lozenges, cosmetic creams, etc.

To learn more, consult our complete guide to legal CBD products in 2025.

Lamaline and CBD association: caution and support

One of the most frequently asked questions in December 2025 concerns the association between Lamaline (an opioid analgesic) and CBD. According to experts from the Cité de la Santé, this association can be considered, but only with pharmaceutical support. Pharmacy advice therefore becomes essential to avoid drug interactions.

CBD around me: local options in pharmacies

The search for CBD products close to home is exploding. The keyword "canna near me" is showing a strong increase on search engines. In response, several French pharmacies are now integrating certified CBD ranges, accessible locally. To discover options near you, visit our article CBD around me.

What problems does CBD in pharmacies solve in 2025?

Chronic pain and daily care

CBD sold in pharmacies is primarily aimed at people suffering from stubborn pain: cancer-related pain, facial neuralgia, muscle stiffness. Where conventional medicines fail, CBD provides complementary relief. It is also used to facilitate sleep or reduce stress, particularly through relaxing oils or hemp-based cosmetic products.

Continuity of medical cannabis treatments

Good news: the medical cannabis experiment in France has been extended until March 31, 2026. This allows patients with severe pathologies (multiple sclerosis, neuropathic pain, etc.) to continue receiving their treatments in pharmacies, with reimbursement by the Health Insurance. This continuity avoids treatment interruptions and reinforces the legitimacy of medical CBD.

Concrete benefits for users in December 2025

Targeted and THC-free relief

Thanks to alternative molecules such as CPR or muscimol, users can benefit from intense relaxation without the psychoactive effects of THC. Products available in pharmacies are controlled, traceable, and compliant with regulations. This allows for daily use with complete peace of mind, whether to improve sleep quality or relieve muscle tension.

Secure and reimbursed access

In 2025, approximately 1800 patients still benefit from the experimental therapeutic cannabis program, with coverage by social security. The generalization study is underway, and pharmacies play a central role in distributing these treatments. For more information, consult our article can one buy pain-relieving CBD in pharmacies without a prescription.

Case studies and recent testimonials

Lamaline and CBD combination: a concrete example

A patient suffering from chronic pain recently integrated CBD into their Lamaline-based treatment. Result: a significant improvement in quality of life, but only thanks to regular follow-up in a pharmacy. This case illustrates the importance of professional support in the combined use of medication and CBD.

MS patients: relief from spasticity

Multiple sclerosis remains one of the main indications for therapeutic cannabis. In 2025, several patients were able to switch to ANSM-approved CBD-based medications, thus ensuring continuity of care in pharmacies.

Integration into daily care routines

More and more people are using CBD to complement their wellness routine: oils for sleep, soothing creams, or balms for joints. These products are now available directly in pharmacies, facilitating access and strengthening user confidence.

Key market figures for 2025

A rapidly growing market

According to a Xerfi study, the French CBD market is expected to reach 900 million euros by the end of 2025. This growth is driven by the expansion of the offering, the legalization of new molecules, and the integration of CBD into official channels such as pharmacies.

The Swiss case: an example to follow

Switzerland lowered the price of 300 medicines in 2025, generating savings of 65 million francs. Over the 2023-2025 cycle, savings reached 335 million francs. These figures show the potential impact of integrating medical cannabis into healthcare systems. More information on pharmaceutical news from December 8 to 12.

Most frequently asked questions in December 2025

Can Lamaline and CBD be combined?

Yes, but with caution. This combination is becoming more frequent, especially for chronic pain. It is essential to go through a pharmacy to benefit from pharmaceutical follow-up and avoid any harmful interactions. For more frequently asked questions, consult our dedicated page: frequently asked questions about CBD in pharmacies.

Where can I find legal CBD near me?

Many pharmacies now offer a range of certified CBD products. To locate points of sale near you, our article CBD around me guides you step by step.

News and trends from December 11 to 18, 2025

Changes in substitution lists

Between December 8 and 12, 2025, several medicines saw their prices drop, including some related to pain and ophthalmology. These adjustments reinforce the favorable context for integrating CBD into official protocols.

Tensions around the taxation of smokable CBD

The 2026 finance law provides for specific taxation on smokable CBD flowers. This measure, expected on December 23, 2025, worries professionals in the sector. Pharmacies, meanwhile, are focusing on non-smokable forms to remain within a secure therapeutic framework. More information on the 2026 finance law.

Increase in local demand

The search for locally accessible CBD products is booming. Pharmacies are adapting by offering varied, secure, and legally compliant ranges. Find all the latest information on canna near me.

CBD in pharmacies is attracting growing interest in France, and research over the last 30 days shows strong demand for information on its legality, availability, quality, and therapeutic uses. Whether you are curious, a patient, or simply looking for a reliable product, here's what you need to know about current trends around CBD in pharmacies.

Can you buy CBD in pharmacies in France?

Yes, it is possible to buy CBD in pharmacies in France, but not all pharmacies systematically offer it. Cannabidiol, or CBD, is legal as long as it respects the regulatory THC thresholds (less than 0.3%). However, availability varies depending on the pharmacy, its internal policy, and its knowledge of the subject.

Pharmacies that sell it promote certified products, often accompanied by laboratory analyzes. To learn more about market trends, you can consult this article on CBD trends in 2025.

What is the difference between CBD sold in pharmacies and in specialized stores?

The question comes up frequently: why choose a pharmacy rather than an online or specialized store? The answer lies in three words: traceability, safety, and advice.

• Traceability: products sold in pharmacies are often accompanied by verifiable Certificates of Analysis (COA).
• Safety: suppliers are selected according to strict criteria, with products compliant with French standards.
• Advice: a pharmacist can guide you according to your needs, your current treatments, and any pathologies you may have.

To delve deeper into the question, you can read this detailed article on CBD in pharmacies.

Is CBD in pharmacies reimbursed or prescribed?

As a general rule, CBD sold freely in pharmacies is not reimbursed by social security. However, as part of the medical cannabis experiment in France, certain prescriptions may include CBD-based products, but only for specific medical indications and in approved hospital centers.

This topic is still evolving. For a complete overview, you can consult this dossier on the future of medical cannabis in France.

What formats of CBD are found in pharmacies?

Pharmacies generally offer sublingual oils, capsules, topical creams, and sometimes infusions. The choice depends on the desired use:

• Oil: for a quick effect and direct absorption.
• Capsules: for precise and discreet dosing.
• Creams: for local use against muscle or joint pain.
• Infusions: for a natural moment of relaxation.

Dosage and drug interactions: what you need to know

CBD dosage should always start low, especially if you are already taking medication. Interactions are possible, particularly with antidepressants, anticoagulants, or antiepileptics. It is therefore crucial to discuss it with your doctor or pharmacist before taking any.

To go further, discover how modern phytotherapy integrates CBD into its therapeutic protocols.

How to verify the authenticity of a CBD product in a pharmacy?

A quality CBD product must absolutely be accompanied by a COA (Certificate of Analysis). This document lists cannabinoid levels, proves the absence of contaminants (pesticides, heavy metals), and guarantees legal compliance.

Pharmacy products are generally more controlled, but it is always good to ask to see these certificates. Some manufacturers even integrate QR codes on their packaging.

Does CBD sold in pharmacies contain THC?

Yes, but in tiny quantities. French legislation requires a THC content of less than 0.3%. This dose is insufficient to cause a psychotropic effect, but it allows for the entourage effect of CBD with the other cannabinoids naturally present in the plant.

The main problems consumers seek to solve

Users of CBD in pharmacies primarily seek to:

• Obtain a reliable product: avoid counterfeits and improperly dosed products.
• Understand interactions with their treatments: especially for chronic diseases.
• Access medical care: within the framework of therapeutic cannabis.
• Find an adapted dosage: for stress, insomnia, or chronic pain.

These concerns are widely discussed in specialized forums and groups. An interesting article to read on this subject is available on CBDouce.

What people do after finding the information

Once well informed, consumers:

1. Go to a pharmacy to buy a safe product.
2. Consult their doctor to adjust their treatment.
3. Test the effectiveness of CBD for a few weeks.
4. Seek a prescription if their condition is eligible for medical cannabis.
5. Compare analysis certificates to choose a quality product.

Frequent doubts about CBD in pharmacies

Several questions come up regularly:

• Is the pharmacist well-trained? Some customers want more guarantees on the competence of pharmacists regarding CBD.
• Are the products more expensive? Yes, but often better controlled.
• Are there side effects? Infrequent, but possible depending on drug interactions.
• Can analyses be trusted? Hence the importance of verifiable COAs.
• Is it really effective? Opinions vary, but many users report an improvement in their quality of life.

User knowledge level: mostly beginners

The majority of searches come from a beginner to intermediate audience. These people are looking for simple information: legality, available formats, starting dosage. But a smaller, more experienced minority is interested in advanced topics such as microdosing, bioavailability, or alternative cannabinoids.

Local searches and recent concerns

Geolocated queries are exploding: "CBD pharmacy Paris", "pharmacy selling CBD in Marseille", etc. Consumers want to know where to buy near them. To meet this demand, discover our local article on CBD in Nîmes.

Furthermore, the ban on oils over 20% since November 2025 has created doubt. This regulation has pushed users towards lighter products or other cannabinoids.

To go further

If you want to better understand market developments, the article by Origine CBD offers a complete analysis of the 2025 context.